Normalization cancer immunotherapy: blocking Siglec-15!
Crossref DOI link: https://doi.org/10.1038/s41392-019-0045-x
Published Online: 2019-04-19
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cao, Guangchao
Xiao, Zhiqiang
Yin, Zhinan
Text and Data Mining valid from 2019-04-19
Version of Record valid from 2019-04-19
Article History
Received: 14 March 2019
Accepted: 19 March 2019
First Online: 19 April 2019
Competing interests
: The authors declare no competing financial interests.